Factors related with symptom duration until diagnosis and treatment of symptomatic colorectal cancer
Authors:
- DECCIRE GROUP*DGDECCIRE GROUP*
- Magdalena EstevaMEMagdalena Esteva
- Alfonso LeivaALAlfonso Leiva
- María RamosMRMaría Ramos
- Salvador Pita-FernándezSPSalvador Pita-Fernández
- Luis González-LujánLGLuis González-Luján
- Montse CasamitjanaMCMontse Casamitjana
- María A SánchezMSMaría A Sánchez
- Sonia Pértega-DíazSPSonia Pértega-Díaz
- Amador RuizARAmador Ruiz
- Paloma Gonzalez-SantamaríaPGPaloma Gonzalez-Santamaría
- María Martín-RabadánMMMaría Martín-Rabadán
Open Access
- 23 February 2013
- journal article
- research article
- Published by Springer Nature in BMC Cancer
- Vol. 13 (1) , 1-13
Abstract
Colorectal cancer (CRC) survival depends mostly on stage at the time of diagnosis. However, symptom duration at diagnosis or treatment have also been considered as predictors of stage and survival. This study was designed to: 1) establish the distinct time-symptom duration intervals; 2) identify factors associated with symptom duration until diagnosis and treatment. This is a cross-sectional study of all incident cases of symptomatic CRC during 2006–2009 (795 incident cases) in 5 Spanish regions. Data were obtained from patients’ interviews and reviews of primary care and hospital clinical records. Measurements: CRC symptoms, symptom perception, trust in the general practitioner (GP), primary care and hospital examinations/visits before diagnosis, type of referral and tumor characteristics at diagnosis. Symptom Diagnosis Interval (SDI) was calculated as time from first CRC symptoms to date of diagnosis. Symptom Treatment Interval (STI) was defined as time from first CRC symptoms until start of treatment. Nonparametric tests were used to compare SDI and STI according to different variables. Symptom to diagnosis interval for CRC was 128 days and symptom treatment interval was 155. No statistically significant differences were observed between colon and rectum cancers. Women experienced longer intervals than men. Symptom presentation such as vomiting or abdominal pain and the presence of obstruction led to shorter diagnostic or treatment intervals. Time elapsed was also shorter in those patients that perceived their first symptom/s as serious, disclosed it to their acquaintances, contacted emergencies services or had trust in their GPs. Primary care and hospital doctor examinations and investigations appeared to be related to time elapsed to diagnosis or treatment. Results show that gender, symptom perception and help-seeking behaviour are the main patient factors related to interval duration. Health service performance also has a very important role in symptom to diagnosis and treatment interval. If time to diagnosis is to be reduced, interventions and guidelines must be developed to ensure appropriate examination and diagnosis during both primary and hospital care.Keywords
This publication has 50 references indexed in Scilit:
- The Aarhus statement: improving design and reporting of studies on early cancer diagnosisBritish Journal of Cancer, 2012
- Most bowel cancer symptoms do not indicate colorectal cancer and polyps: a systematic reviewBMC Gastroenterology, 2011
- Social support, gender and patient delayBritish Journal of Cancer, 2011
- Time to diagnosis and mortality in colorectal cancer: a cohort study in primary careBritish Journal of Cancer, 2011
- Does delay in diagnosing colorectal cancer in symptomatic patients affect tumor stage and survival? A population-based observational studyBMC Cancer, 2010
- Determining the date of diagnosis – is it a simple matter? The impact of different approaches to dating diagnosis on estimates of delayed care for ovarian cancer in UK primary careBMC Medical Research Methodology, 2009
- Missed Opportunities to Initiate Endoscopic Evaluation for Colorectal Cancer DiagnosisAmerican Journal of Gastroenterology, 2009
- A self administered reliable questionnaire to assess lower bowel symptomsBMC Gastroenterology, 2008
- Influences on pre-hospital delay in the diagnosis of colorectal cancer: a systematic reviewBritish Journal of Cancer, 2007
- Recent cancer survival in Europe: a 2000–02 period analysis of EUROCARE-4 dataThe Lancet Oncology, 2007